seed finding
BUSINESS APPROACH




Seed opportunities may be

  1. pre-existing, early stage spin-outs

  2. opportunities to build new biotech projects from the seeds of university research

SEED FINDING CHALLENGE


Though companies can enhance their immediate portfolio of launched products through M&A and strike key deals with biotechs for compounds still in clinical trials, even the largest pharmaceutical companies now realise that selecting and progressing good projects for Drug Discovery can benefit from external input.


As a result, Outsourcing, Partnering, Open Innovation and Translation Research are the words of the day.


  1. But how do you make an external strategy succeed?

  2. How do you do improve progress through using external partners, rather than progressing everything internally?

  3. How do you succeed rather than just failing in a different way?

FREQUENTLY ASKED QUESTIONS


Q: We already approach University TLOs, how can you help?

A: We approach scientists directly and have a total project plan in mind.


Q: Are there other considerations?

A: Tax incentives and grants sometimes exist which can reduce costs. Different countries and regions have different incentives.


Q: Will a pharmaceutical company really consider re-use of their historical assets?

A: There are already examples. Yamanouchi licensed PI3 kinase work to group that became Piramed. Akebia was founded on assets from Procter and Gamble. Provided a proposal is reasonable there should be a chance of acceptance.


Q: How do you do it?

A: We use a combination of robust analytics developed from our informatics backgrounds and soft skills especially effective ‘peer-to-peer’ approaches, to identify candidate sources.

ebisu STEPS FOR SUCCESS


  1. Recognise that expertise in newer technologies almost certainly resides outside pharmaceutical companies

  2. Utilise university groups that have been researching the area for years, possibly decades. They are the best source of domain exptertise.


  1. Not all academics are entrepreneurs. Ensure the academic partners are positioned correctly in any spinout.


  1. Ensure that any adoption of new approaches is cost-effective. No single invention provides a ‘golden solution’ to drug discovery.


  1. Embrace opportunities to perform projects outside the company where expertise is recognised.

University
Group
University
Group
Outsourced
Provider
Technology
IP

SEED

Services
Management